Títulos de anticuerpos neutralizantes en sueros de individuos posconvalescientes con dengue
Álvarez Vera, Mayling; Díaz Morejón, Danay; Rodríguez Roche, Rosmari; Morier Diaz, Luis; Guzmán Tirado, María G.
Rev. cuba. med. trop
; 66(1): 132-142, ene.-mar. 2014.
Artículo en Español | CUMED | ID: cum-58219
Documentos relacionados
Global and cell type-specific immunological hallmarks of severe dengue progression identified via a systems immunology approach.
Severe dengue progression beyond enhancement.
The Immunogenicity of DENV1-4 ED3s Strongly Differ despite Their Almost Identical Three-Dimensional Structures and High Sequence Similarities.
Experimental in vitro and in vivo systems for studying the innate immune response during dengue virus infections.
Dengue virus non-structural protein 1: a pathogenic factor, therapeutic target, and vaccine candidate.
Genetic diversity of the dengue virus population in dengue fever and dengue hemorrhagic fever patients.
Maternally derived antibody titer dynamics and risk of hospitalized infant dengue disease.
Integrated systems immunology approach identifies impaired effector T cell memory responses as a feature of progression to severe dengue fever.
Knowledge gaps in the epidemiology of severe dengue impede vaccine evaluation.
Clinical-epidemiological characteristics of deaths due to dengue during an outbreak in northern Peru.